Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study.
BACKGROUND:Though the associations between low serum 25-hydroxyvitamin D (25(OH)D) levels and health outcomes such as type 2 diabetes (T2D), myocardial infarction (MI), cancer, and mortality are well-studied, the effect of supplementation with vitamin D is uncertain. This may be related to genetic d...
Main Authors: | Ieva Zostautiene, Rolf Jorde, Henrik Schirmer, Ellisiv Bøgeberg Mathiesen, Inger Njølstad, Maja-Lisa Løchen, Tom Wilsgaard, Ragnar Martin Joakimsen, Elena Kamycheva |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4689352?pdf=render |
Similar Items
-
Correction: Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study.
by: Ieva Martinaityte, et al.
Published: (2016-01-01) -
The DBP Phenotype Gc-1f/Gc-1f Is Associated with Reduced Risk of Cancer. The Tromsø Study.
by: Rolf Jorde, et al.
Published: (2015-01-01) -
Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study.
by: Rolf Jorde, et al.
Published: (2012-01-01) -
Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromsø Study
by: Joakim K. Sejrup, et al.
Published: (2020-02-01) -
Hypothetical interventions and risk of myocardial infarction in a general population: application of the parametric g-formula in a longitudinal cohort study—the Tromsø Study
by: Goodarz Danaei, et al.
Published: (2020-05-01)